2,117
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Impact of particle size of multivesicular liposomes on the embolic and therapeutic effects in rabbit VX2 liver tumor

ORCID Icon, , &
Pages 1-16 | Received 07 Aug 2022, Accepted 06 Dec 2022, Published online: 16 Jan 2023

References

  • Bargellini I, Lorenzoni V, Lorenzoni G, et al. (2021). Duration of response after DEB-TACE compared to lipiodol-TACE in HCC-naïve patients: a propensity score matching analysis. Eur Radiol 31:7512–22.
  • Bulbake U, Doppalapudi S, Kommineni N, et al. (2017). Liposomal formulations in clinical use: an updated review. Pharmaceutics 9:12.
  • Chang W-C, Hsu H-H, Chiu S-H, et al. (2021). Transcatheter arterial chemoembolization with drug-eluting beads for the treatment of hepatocellular carcinoma: recommended selection for small-caliber. JHC 8:937–49.
  • Chen M, Li J, Shu G, et al. (2022). Homogenous multifunctional microspheres induce ferroptosis to promote the anti-hepatocarcinoma effect of chemoembolization. J Nanobiotechnol 20:179.
  • Claessens MMAE, van Oort BF, Leermakers FAM, et al. (2004). Charged lipid vesicles: effects of salts on bending rigidity, stability, and size. Biophys J 87:3882–93.
  • Del Poggio P, Maddeo A, Zabbialini G, et al. (2007). Chemoembolization of hepatocellular carcinoma with drug eluting beads. J Hepatol 47:157–8; author reply 159.
  • Fan W, Guo J, Zhu B, et al. (2021). Drug-eluting beads TACE is safe and non-inferior to conventional TACE in HCC patients with TIPS. Eur Radiol 31:8291–301.
  • Grabarnick Portnoy E, Andriyanov AV, Han H, et al. (2021). PEGylated liposomes remotely loaded with the combination of doxorubicin, quinine, and indocyanine green enable successful treatment of multidrug-resistant tumors. Pharmaceutics 13:2181.
  • Hidaka T, Anai H, Sakaguchi H, et al. (2021). Efficacy of combined bland embolization and chemoembolization for huge (≥10 cm) hepatocellular carcinoma. Minim Invasive Ther Allied Technol 30:221–8.
  • Hu J, Albadawi H, Chong BW, et al. (2019). Advances in biomaterials and technologies for vascular embolization. Adv Mater 31:1901071.
  • Hucke F, Pinter M, Hucke M, et al. (2022). Changing epidemiological trends of hepatobiliary carcinomas in Austria 2010–2018. Cancers 14:3093.
  • Imamura A, Taguchi H, Takano H, et al. (2021). Whole-liver transcatheter arterial chemoinfusion and bland embolization with fine-powder cisplatin and trisacryl gelatin microspheres for treating unresectable multiple hepatocellular carcinoma. Jpn J Radiol 39:494–502.
  • Jang ES, Jeong S-H, Kim JW, et al. (2009). A case of acute ischemic duodenal ulcer associated with superior mesenteric artery dissection after transarterial chemoembolization for hepatocellular carcinoma. Cardiovasc Intervent Radiol 32:367–70.
  • Kerbel RS, Kamen BA. (2004). The anti-angiogenic basis of metronomic chemotherapy. Nat Rev Cancer 4:423–36.
  • Lee M-Y, Chuang VP, Wei C-J, et al. (2012). Histopathologic correlation of hepatocellular carcinoma after transcatheter arterial chemoembolization with polyvinyl alcohol particle of various sizes. Eur J Radiol 81:1976–9.
  • Li N, Shi A, Wang Q, Zhang G. (2019). Multivesicular Liposomes for the Sustained Release of Angiotensin I-Converting Enzyme (ACE) Inhibitory Peptides from Peanuts: Design, Characterization, and In Vitro Evaluation. Molecules 24(9):1746.
  • Li N, Shi A, Wang Q, et al. (2019). Multivesicular liposomes for the sustained release of angiotensin i-converting enzyme (ACE) inhibitory peptides from peanuts: design, characterization, and in vitro evaluation. Molecules 24:1746.
  • Liang Y-J, Yu H, Feng G, et al. (2017). High-performance poly(lactic-co-glycolic acid)-magnetic microspheres prepared by rotating membrane emulsification for transcatheter arterial embolization and magnetic ablation in VX(2) liver tumors. ACS Appl Mater Interfaces 9:43478–89.
  • Lin SY, Wu W, Lui W. (1992). In vitro release, pharmacokinetic and tissue distribution studies of doxorubicin hydrochloride (Adriamycin HCl) encapsulated in lipiodolized w/o emulsions and w/o/w multiple emulsions. Die Pharmazie 47:439.
  • Liu Y-S, Ou M-C, Tsai Y-S, et al. (2015). Transarterial chemoembolization using gelatin sponges or microspheres plus lipiodol-doxorubicin versus doxorubicin-loaded beads for the treatment of hepatocellular carcinoma. Korean J Radiol 16:125.
  • Loffroy R, Guillen K, Salet E, et al. (2021). Prostate artery embolization using N-butyl cyanoacrylate glue for urinary tract symptoms due to benign prostatic hyperplasia: a valid alternative to microparticles? J Clin Med 10:3161.
  • Loffroy R, Guiu B, Cercueil J-P, et al. (2009). Endovascular therapeutic embolisation: an overview of occluding agents and their effects on embolised tissues. Curr Vasc Pharmacol 7:250–63.
  • Lu D-E, Cheng S-W, Lin Y-S, et al. (2022). Combination of radiofrequency ablation and percutaneous ethanol injection versus radiofrequency ablation alone for hepatocellular carcinoma: a systematic review and meta-analysis. Ann Hepatol 27:100729.
  • Maeda N, Verret V, Moine L, et al. (2013). Targeting and recanalization after embolization with calibrated resorbable microspheres versus hand-cut gelatin sponge particles in a porcine kidney model. J Vasc Interv Radiol 24:1391–8.
  • Maluccio MA, Covey AM, Porat LB, et al. (2008). Transcatheter arterial embolization with only particles for the treatment of unresectable hepatocellular carcinoma. J Vasc Interv Radiol 19:862–9.
  • Mantripragada S. (2002). A lipid based depot (DepoFoam technology) for sustained release drug delivery. Prog Lipid Res 41:392–406.
  • Odisio BC, Ashton A, Yan Y, et al. (2015). Transarterial hepatic chemoembolization with 70–150 µm drug-eluting beads: assessment of clinical safety and liver toxicity profile. J Vasc Interv Radiol 26:965–71.
  • Park M, Kim JY, Kim J, et al. (2021). Low-dose metronomic doxorubicin inhibits mobilization and differentiation of endothelial progenitor cells through REDD1-mediated VEGFR-2 downregulation. BMB Rep 54:470–5.
  • Qiu J, Wei X-h, Geng F, et al. (2005). Multivesicular liposome formulations for the sustained delivery of interferon alpha-2b. Acta Pharmacol Sin 26:1395–401.
  • Shaked Y, Emmenegger U, Francia G, et al. (2005). Low-dose metronomic combined with intermittent bolus-dose cyclophosphamide is an effective long-term chemotherapy treatment strategy. Cancer Res 65:7045–51.
  • Shen Y, Ji Y, Xu S, et al. (2011). Multivesicular liposome formulations for the sustained delivery of ropivacaine hydrochloride: preparation, characterization, and pharmacokinetics. Drug Deliv 18:361–6.
  • Shi Q, Li T, Huang S, et al. (2021). Transcatheter arterial embolization containing donafenib induces anti-angiogenesis and tumoricidal CD8+ T-Cell infiltration in rabbit VX2 Liver tumor. Cancer Manag Res 13:6943–52.
  • Shim JH, Park J-W, Kim JH, et al. (2008). Association between increment of serum VEGF level and prognosis after transcatheter arterial chemoembolization in hepatocellular carcinoma patients. Cancer Sci 99:2037–44.
  • Shimohira M, Ogino H, Kawai T, et al. (2011). Use of the triaxial microcatheter method in super-selective transcatheter arterial chemoembolisation for hepatocellular carcinoma. Br J Radiol 84:184–7.
  • Spector MS, Zasadzinski JA, Sankaram MB. (1996). Topology of multivesicular liposomes, a model biliquid foam. Langmuir 12:4704–8.
  • Sun B, Zhang W, Chen L, et al. (2022). The safety and efficacy of percutaneous ethanol injection in the treatment of tumor thrombus in advanced hepatocellular carcinoma with portal vein tumor thrombus. Abdom Radiol 47:858–68.
  • Sun L, Wang T, Gao L, et al. (2013). Multivesicular liposomes for sustained release of naltrexone hydrochloride: design, characterization and in vitro/in vivo evaluation. Pharm Dev Technol 18:828–33.
  • Takata K, Tanaka T, Anan A, et al. (2022). Suppression of local tumor progression in perivascular hepatocellular carcinoma by combination therapy with radiofrequency ablation and percutaneous ethanol injection: a propensity score matching analysis. Oncology 100:303–12.
  • Tsai K-Y, Chen H-A, Wang W-Y, et al. (2019). Long-term and short-term surgical outcomes of laparoscopic versus open liver resection for hepatocellular carcinoma: might laparoscopic approach be better in early HCC? Surg Endosc 33:1131–9.
  • Wang H, Li Y, Qi Y, et al. (2022). Pegylated liposomal doxorubicin, docetaxel, and trastuzumab as neoadjuvant treatment for HER2-positive breast cancer patients: a phase II and biomarker study. Front Oncol 12:909426.
  • Wang T, Gao L, Quan D. (2011). Multivesicular liposome (MVL) sustained delivery of a novel synthetic cationic GnRH antagonist for prostate cancer treatment. J Pharm Pharmacol 63:904–10.
  • Yildiz I, Deniz S, Ozer A, et al. (2022). Trans-arterial chemoembolization with 50 μm degradable starch microspheres versus 300–500 μm drug eluting beads in hepatocellular carcinoma: a comparative analysis of initial treatment outcomes. J Belg Soc Radiol 106:10.
  • Zeng J, Li L, Zhang H, et al. (2018). Radiopaque and uniform alginate microspheres loaded with tantalum nanoparticles for real-time imaging during transcatheter arterial embolization. Theranostics 8:4591–600.